Wemade Heralds Special MIR4 Global New Year’s Event
14.12.2021 08:28:00 EET | Business Wire | Press release
In exciting news for MMORPG ‘MIR4’ fans, Wemade is celebrating the New Year with a special event, beginning December 14th and continuing into 2022. The opening of a new region, Phantasia, and new content updates for Boss Raid and character NFT releases will follow on December 21st.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211212005117/en/
Wemade celebrates the New Year with a special event, beginning December 14th and continuing into 2022 for MIR4 fans. The opening of a new region, Phantasia, and new content updates for Boss Raid and character NFT releases will follow on December 21st. Throughout the four-week-long event, players can receive an abundance of special rewards, including Epic Challenge Incense Burner Box, Socks of Wishes, and Cordials that can be consumed to support the growth of a character. (Graphic: Business Wire)
Throughout the four-week-long event, players can receive an abundance of special rewards, including: Epic Challenge Incense Burner Box, Socks of Wishes (containing Magic Square tickets, Secret Peak tickets), and Cordials that can be consumed to support the growth of a character. There will also be a hunting event for two weeks from December 28th. Players can obtain Wish Letters by hunting monsters in the MIR continent and exchange these from NPCs in town to get various Enhancement Stones and Blue Dragon Statues.
The release of Phantasia will reveal a completely new area of the MIR continent. This new expansion will unveil fields such as: the Phantasia Desert, Ant Hole, Sabuk Province, and Sabuk Castle Underground Jail. Players will be able to enjoy a vast amount of newly added quests, missions, and requests. ‘MIR4’ will also increase the maximum level limit to 130 as part of this update. Conquest structures’ maximum stage levels will also be increased to stage 17 – when the Tower of Conquest reaches stage 17, players will be eligible to reach the maximum level 130 for their characters.
Other new content will be updated to enable further character growth:
- The maximum constitution tier will increase to Tier 13
- Three Inner Forces will be unlocked (Violet Mist Art, Northern Profound Art, and Toad Stance)
- A new mystery, Bok Yangjeo, will be added
Additional content updates for high-level players will include:
- Boss Raid ‘Forsaken King’
- Boss Raid ‘Crimson Dragon Nest’
- Clan Expedition ‘Blue Thunder Dragon’
December 21st will set the launch of a new NFT exchange where characters can be traded. Players will be able to seal characters that are above level 60 and have a Power Score of 100,000 or more, and exchange with other players as NFTs. Players will gain recognition for ownership of their characters they have worked so hard to raise and will be able to conduct player-to-player trades using a safe and secure transaction system in the NFT exchange.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211212005117/en/
Contact information
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom